159 related articles for article (PubMed ID: 3829596)
1. AMP deaminase deficiency: study of the human skeletal muscle purine metabolism during ischaemic isometric exercise.
Sinkeler SP; Binkhorst RA; Joosten EM; Wevers RA; Coerwinkei MM; Oei TL
Clin Sci (Lond); 1987 Apr; 72(4):475-82. PubMed ID: 3829596
[TBL] [Abstract][Full Text] [Related]
2. Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle.
Sabina RL; Swain JL; Olanow CW; Bradley WG; Fishbein WN; DiMauro S; Holmes EW
J Clin Invest; 1984 Mar; 73(3):720-30. PubMed ID: 6707201
[TBL] [Abstract][Full Text] [Related]
3. Disruption of the purine nucleotide cycle. A potential explanation for muscle dysfunction in myoadenylate deaminase deficiency.
Sabina RL; Swain JL; Patten BM; Ashizawa T; O'Brien WE; Holmes EW
J Clin Invest; 1980 Dec; 66(6):1419-23. PubMed ID: 7440723
[TBL] [Abstract][Full Text] [Related]
4. Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans.
Tarnopolsky MA; Parise G; Gibala MJ; Graham TE; Rush JW
J Physiol; 2001 Jun; 533(Pt 3):881-9. PubMed ID: 11410643
[TBL] [Abstract][Full Text] [Related]
5. Muscle metabolism and red cell ATP/ADP concentration during bicycle ergometer in patients with AMPD-deficiency.
Wagner DR; Felbel J; Gresser U; Zöllner N
Klin Wochenschr; 1991 Apr; 69(6):251-5. PubMed ID: 2038174
[TBL] [Abstract][Full Text] [Related]
6. Ischaemic exercise test in myoadenylate deaminase deficiency and McArdle's disease: measurement of plasma adenosine, inosine and hypoxanthine.
Sinkeler SP; Joosten EM; Wevers RA; Binkhorst RA; Oerlemans FT; van Bennekom CA; Coerwinkel MM; Oei TL
Clin Sci (Lond); 1986 Apr; 70(4):399-401. PubMed ID: 3457669
[TBL] [Abstract][Full Text] [Related]
7. Muscle ammonia metabolism during isometric contraction in humans.
Katz A; Sahlin K; Henriksson J
Am J Physiol; 1986 Jun; 250(6 Pt 1):C834-40. PubMed ID: 2872818
[TBL] [Abstract][Full Text] [Related]
8. Skeletal muscle adenosine, inosine and hypoxanthine release following ischaemic forearm exercise in myoadenylate deaminase deficiency and McArdle's disease.
Sinkeler S; Joosten E; Wevers R; Binkhorst R; Oei L
Adv Exp Med Biol; 1986; 195 Pt B():517-23. PubMed ID: 3464164
[TBL] [Abstract][Full Text] [Related]
9. Exercising muscle does not produce hypoxanthine in adenylate deaminase deficiency.
Patterson VH; Kaiser KK; Brooke MH
Neurology; 1983 Jun; 33(6):784-6. PubMed ID: 6682523
[TBL] [Abstract][Full Text] [Related]
10. Myoadenylate deaminase deficiency and forearm ischemic exercise testing.
Valen PA; Nakayama DA; Veum J; Sulaiman AR; Wortmann RL
Arthritis Rheum; 1987 Jun; 30(6):661-8. PubMed ID: 3606685
[TBL] [Abstract][Full Text] [Related]
11. Myoadenylate deaminase deficiency: a new disease of muscle.
Fishbein WN; Armbrustmacher VW; Griffin JL
Science; 1978 May; 200(4341):545-8. PubMed ID: 644316
[TBL] [Abstract][Full Text] [Related]
12. AMP deaminase deficiency is associated with lower sprint cycling performance in healthy subjects.
Fischer H; Esbjörnsson M; Sabina RL; Strömberg A; Peyrard-Janvid M; Norman B
J Appl Physiol (1985); 2007 Jul; 103(1):315-22. PubMed ID: 17463303
[TBL] [Abstract][Full Text] [Related]
13. Myoadenylate deaminase deficiency: inherited and acquired forms.
Fishbein WN
Biochem Med; 1985 Apr; 33(2):158-69. PubMed ID: 4004819
[TBL] [Abstract][Full Text] [Related]
14. Effects of oral ribose on muscle metabolism during bicycle ergometer in AMPD-deficient patients.
Wagner DR; Gresser U; Zöllner N
Ann Nutr Metab; 1991; 35(5):297-302. PubMed ID: 1776826
[TBL] [Abstract][Full Text] [Related]
15. Effects of pharmacological AMP deaminase inhibition and Ampd1 deletion on nucleotide levels and AMPK activation in contracting skeletal muscle.
Plaideau C; Lai YC; Kviklyte S; Zanou N; Löfgren L; Andersén H; Vertommen D; Gailly P; Hue L; Bohlooly-Y M; Hallén S; Rider MH
Chem Biol; 2014 Nov; 21(11):1497-1510. PubMed ID: 25459662
[TBL] [Abstract][Full Text] [Related]
16. Myoadenylate deaminase deficiency: an enzyme defect in search of a disease.
Joosten E; van Bennekom C; Oerlemans F; De Bruyn C; Oei T; Trijbels J
Adv Exp Med Biol; 1984; 165 Pt A():85-9. PubMed ID: 6720421
[TBL] [Abstract][Full Text] [Related]
17. Purine nucleotides and AMP deamination during maximal and endurance swimming exercise in heart and skeletal muscle of rats.
Weicker H; Hageloch W; Luo J; Müller D; Werle E; Sehling KM
Int J Sports Med; 1990 May; 11 Suppl 2():S68-77. PubMed ID: 2361782
[TBL] [Abstract][Full Text] [Related]
18. Levels of adenylate deaminase, adenylate kinase, and creatine kinase in frozen human muscle biopsy specimens relative to type 1/type 2 fiber distribution: evidence for a carrier state of myoadenylate deaminase deficiency.
Fishbein WN; Armbrustmacher VW; Griffin JL; Davis JI; Foster WD
Ann Neurol; 1984 Mar; 15(3):271-7. PubMed ID: 6326659
[TBL] [Abstract][Full Text] [Related]
19. Integrating metabolic pathways in post-exercise recovery of white muscle.
Schulte PM; Moyes CD; Hochachka PW
J Exp Biol; 1992 May; 166():181-95. PubMed ID: 1602273
[TBL] [Abstract][Full Text] [Related]
20. Myoadenylate deaminase deficiency: diagnosis by forearm ischemic exercise testing.
Valen PA; Nakayama DA; Veum JA; Wortmann RL
Adv Exp Med Biol; 1986; 195 Pt B():525-8. PubMed ID: 3766241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
